NYSE : GMED
Globus Medical, Inc. — Financial statements
Healthcare · Medical Devices · United States
Last price 78.05 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 10.48B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Globus Medical, Inc. (GMED) reported revenue of 3.14B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 3.14B | 2.94B | 2.52B | 1.57B | 1.02B | 958.10M |
| Cost of Revenue | 975.71M | 938.35M | 819.88M | 476.52M | 262.83M | 239.22M |
| Gross Profit | 2.17B | 2.00B | 1.70B | 1.09B | 760.01M | 718.88M |
| Selling, General & Admin | 1.17B | 1.14B | 977.48M | 643.41M | 432.12M | 408.15M |
| Research & Development | 147.06M | 146.94M | 161.60M | 124.01M | 73.02M | 97.35M |
| Amortization of Goodwill & Intangibles | 118.29M | 118.19M | 119.37M | 51.03M | 17.73M | 18.53M |
| Operating Expenses | 1.44B | 1.40B | 1.26B | 818.45M | 522.87M | 524.02M |
| Operating Income | 730.32M | 600.27M | 441.03M | 273.51M | 237.15M | 194.86M |
| Interest Expense | -4.19M | |||||
| Interest & Investment Income | 17.27M | 7.14M | 20.13M | 14.23M | 9.30M | |
| Currency Exchange Gain (Loss) | -10.29M | -3.01M | -43.28M | 14.26M | -1.02M | -1.42M |
| Other Non Operating Income (Expenses) | 5.35M | 3.41M | 2.21M | -2.14M | 7.24M | 3.36M |
| EBT Excluding Unusual Items | 742.65M | 607.82M | 395.76M | 305.76M | 257.60M | 206.09M |
| Merger & Restructuring Charges | -47.69M | -77.35M | -274.72M | -139.93M | -6.85M | -16.98M |
| Gain (Loss) on Sale of Investments | -5.39M | -2.78M | ||||
| Legal Settlements | -43.10M | -43.10M | -314.00K | -434.00K | -2.34M | -5.92M |
| Other Unusual Items | 8.26M | 117.70M | ||||
| Pretax Income | 660.12M | 605.07M | 120.72M | 165.39M | 243.02M | 180.41M |
| Income Tax Expense | 124.69M | 67.20M | 17.74M | 42.52M | 52.85M | 31.22M |
| Net Income | 535.43M | 537.87M | 102.98M | 122.87M | 190.17M | 149.19M |
| Net Income to Common | 535.43M | 537.87M | 102.98M | 122.87M | 190.17M | 149.19M |
| Shares Outstanding (Basic) | 134.83M | 135.22M | 135.73M | 113.09M | 100.47M | 100.73M |
| Shares Outstanding (Diluted) | 136.88M | 137.06M | 137.86M | 114.63M | 102.64M | 103.62M |
| EPS (Basic) | 3.97 | 3.98 | 0.76 | 1.09 | 1.89 | 1.48 |
| EPS (Diluted) | 3.91 | 3.92 | 0.75 | 1.07 | 1.85 | 1.44 |
| Free Cash Flow | 755.59M | 588.77M | 405.21M | 165.22M | 104.42M | 219.38M |
| Free Cash Flow Per Share | 5.52 | 4.30 | 2.94 | 1.44 | 1.02 | 2.12 |
| Gross Margin | 68.97% | 68.07% | 67.46% | 69.62% | 74.30% | 75.03% |
| Operating Margin | 23.22% | 20.42% | 17.51% | 17.44% | 23.18% | 20.34% |
| Profit Margin | 17.03% | 18.30% | 4.09% | 7.83% | 18.59% | 15.57% |
| Free Cash Flow Margin | 24.03% | 20.03% | 16.08% | 10.53% | 10.21% | 22.90% |
| EBITDA | 1.01B | 877.11M | 694.41M | 419.03M | 305.40M | 264.73M |
| EBITDA Margin | 32.12% | 29.84% | 27.56% | 26.72% | 29.86% | 27.63% |
| D&A For EBITDA | 279.98M | 276.84M | 253.39M | 145.53M | 68.25M | 69.87M |
| EBIT | 730.32M | 600.27M | 441.03M | 273.51M | 237.15M | 194.86M |
| EBIT Margin | 23.22% | 20.42% | 17.51% | 17.44% | 23.18% | 20.34% |
| Effective Tax Rate | 18.89% | 11.11% | 14.69% | 25.71% | 21.75% | 17.30% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 507.75M | 526.16M | 784.44M | 467.29M | 150.47M | 193.07M |
| Short-Term Investments | 87.40M | 31.09M | 105.62M | 50.50M | 295.59M | 250.38M |
| Cash & Short-Term Investments | 595.14M | 557.24M | 890.06M | 517.79M | 446.06M | 443.45M |
| Accounts Receivable | 692.18M | 678.94M | 557.70M | 503.24M | 213.25M | 164.44M |
| Other Receivables | 47.10M | 64.73M | 20.63M | 1.64M | 4.06M | 1.22M |
| Receivables | 739.28M | 743.66M | 578.33M | 504.87M | 217.31M | 165.65M |
| Inventory | 810.90M | 759.28M | 659.23M | 848.13M | 298.98M | 237.00M |
| Prepaid Expenses | 70.19M | 65.43M | 49.64M | 44.58M | 21.00M | 18.42M |
| Total Current Assets | 2.22B | 2.13B | 2.18B | 1.92B | 983.34M | 864.52M |
| Property, Plant & Equipment | 593.38M | 628.96M | 612.07M | 647.66M | 249.72M | 221.08M |
| Long-Term Investments | 245.36M | 71.82M | 66.13M | 75.43M | 495.85M | 562.48M |
| Goodwill | 1.44B | 1.44B | 1.43B | 1.43B | 197.47M | 179.71M |
| Other Intangible Assets | 692.62M | 745.06M | 795.12M | 924.60M | 63.57M | 68.66M |
| Long-Term Deferred Tax Assets | 224.63M | 218.22M | 94.20M | 10.69M | 48.84M | 24.49M |
| Other Long-Term Assets | 78.54M | 78.06M | 74.58M | 77.79M | 37.32M | 36.33M |
| Total Assets | 5.49B | 5.30B | 5.25B | 5.09B | 2.08B | 1.96B |
| Accounts Payable | 106.94M | 98.85M | 75.12M | 56.67M | 36.10M | 21.95M |
| Accrued Expenses | 247.94M | 281.36M | 253.61M | 230.65M | 86.61M | 87.24M |
| Current Portion of Long-Term Debt | 443.35M | |||||
| Current Portion of Leases | 14.72M | 15.09M | 10.48M | 12.44M | 2.54M | |
| Current Income Taxes Payable | 6.04M | 4.16M | 10.72M | 3.85M | 990.00K | 1.05M |
| Current Unearned Revenue | 27.98M | 27.66M | 22.14M | 18.37M | 14.10M | 12.03M |
| Other Current Liabilities | 75.73M | 71.39M | 40.48M | 70.37M | 18.87M | 17.89M |
| Total Current Liabilities | 479.35M | 498.50M | 855.91M | 392.35M | 159.20M | 140.16M |
| Long-Term Debt | 417.40M | |||||
| Long-Term Leases | 97.19M | 104.35M | 83.89M | 91.37M | 3.48M | |
| Long-Term Deferred Tax Liabilities | 42.34M | 23.76M | 23.89M | 84.42M | 1.78M | 4.31M |
| Other Long-Term Liabilities | 100.78M | 102.90M | 110.73M | 102.58M | 65.30M | 71.40M |
| Total Liabilities | 719.65M | 729.51M | 1.07B | 1.09B | 229.75M | 215.88M |
| Common Stock | 134.00K | 135.00K | 137.00K | 136.00K | 100.00K | 101.00K |
| Additional Paid-In Capital | 3.23B | 3.17B | 3.03B | 2.87B | 630.95M | 553.79M |
| Retained Earnings | 1.53B | 1.39B | 1.15B | 1.14B | 1.24B | 1.19B |
| Comprehensive Income & Other | 11.20M | 15.35M | -6.86M | -10.19M | -24.63M | -6.77M |
| Shareholders' Equity | 4.77B | 4.57B | 4.18B | 4.00B | 1.85B | 1.74B |
| Total Liabilities & Equity | 5.49B | 5.30B | 5.25B | 5.09B | 2.08B | 1.96B |
| Total Debt | 111.91M | 119.44M | 537.72M | 521.22M | 6.01M | |
| Net Cash (Debt) | 728.59M | 509.62M | 418.47M | 72.00M | 935.90M | 1.01B |
| Net Cash Per Share | 5.32 | 3.72 | 3.04 | 0.63 | 9.12 | 9.71 |
| Filing Date Shares Outstanding | 134.26M | 135.25M | 137.54M | 135.37M | 100.30M | 101.56M |
| Total Common Shares Outstanding | 134.25M | 135.06M | 137.42M | 136.34M | 100.19M | 101.54M |
| Working Capital | 1.74B | 1.63B | 1.32B | 1.52B | 824.14M | 724.35M |
| Book Value Per Share | 35.52 | 33.86 | 30.40 | 29.32 | 18.43 | 17.15 |
| Tangible Book Value | 2.64B | 2.39B | 1.95B | 1.64B | 1.59B | 1.49B |
| Tangible Book Value Per Share | 19.65 | 17.72 | 14.19 | 12.02 | 15.82 | 14.70 |
| Land | 10.81M | 10.85M | 9.73M | 9.75M | 8.28M | 8.30M |
| Buildings | 127.77M | 127.57M | 100.13M | 102.45M | 51.51M | 44.67M |
| Machinery | 1.09B | 1.07B | 956.23M | 878.41M | 508.88M | 443.25M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 535.43M | 537.87M | 102.98M | 122.87M | 190.17M | 149.19M |
| Depreciation & Amortization | 279.98M | 276.84M | 253.39M | 145.53M | 68.25M | 69.87M |
| Loss (Gain) From Sale of Assets | 11.95M | 12.53M | 5.55M | 1.54M | 299.00K | 464.00K |
| Asset Writedown & Restructuring Costs | 12.61M | 150.00K | 34.31M | |||
| Loss (Gain) From Sale of Investments | 5.39M | 2.78M | ||||
| Stock-Based Compensation | 48.96M | 49.78M | 54.19M | 52.74M | 32.81M | 30.59M |
| Provision & Write-off of Bad Debts | 16.07M | 10.22M | 16.99M | 3.66M | -1.00K | 1.20M |
| Other Operating Activities | 120.95M | -67.00M | 172.48M | 33.76M | -13.34M | 5.12M |
| Change in Accounts Receivable | -99.79M | -52.18M | -78.06M | -49.91M | -50.84M | -25.89M |
| Change in Inventory | -50.43M | -17.60M | -29.86M | -70.33M | -61.74M | -11.97M |
| Change in Accounts Payable | 17.96M | 8.49M | 17.66M | -14.22M | 14.42M | 3.68M |
| Change in Income Taxes | 7.16M | -50.85M | -13.38M | -408.00K | -2.89M | 5.21M |
| Change in Other Net Operating Assets | 22.14M | 45.35M | 6.08M | 18.27M | -4.21M | 11.72M |
| Operating Cash Flow | 910.39M | 753.45M | 520.64M | 243.50M | 178.47M | 276.27M |
| Capital Expenditures | -154.80M | -164.68M | -115.43M | -78.27M | -74.05M | -56.90M |
| Cash Acquisitions | -1.41M | -252.55M | -17.64M | -296.03M | -31.43M | -34.49M |
| Sale (Purchase) of Intangibles | -9.75M | -9.75M | ||||
| Investment in Securities | -333.06M | 71.96M | -42.99M | 677.27M | -4.88M | -284.55M |
| Investing Cash Flow | -499.01M | -355.01M | -176.05M | 302.97M | -110.36M | -375.94M |
| Long-Term Debt Repaid | -449.99M | |||||
| Net Debt Issued (Repaid) | -449.99M | |||||
| Issuance of Common Stock | 110.77M | 89.76M | 110.44M | 12.40M | 41.72M | 63.50M |
| Repurchase of Common Stock | -224.47M | -303.36M | -92.52M | -236.18M | -144.49M | |
| Other Financing Activities | -21.43M | -15.57M | -45.62M | -8.04M | -7.18M | -9.35M |
| Financing Cash Flow | -135.13M | -679.16M | -27.70M | -231.82M | -109.96M | 54.15M |
| Foreign Exchange Rate Adjustments | 2.05M | 22.45M | 255.00K | 2.18M | -747.00K | -810.00K |
| Net Cash Flow | 278.30M | -258.28M | 317.15M | 316.83M | -42.60M | -46.33M |
| Free Cash Flow | 755.59M | 588.77M | 405.21M | 165.22M | 104.42M | 219.38M |
| Free Cash Flow Margin | 24.03% | 20.03% | 16.08% | 10.53% | 10.21% | 22.90% |
| Free Cash Flow Per Share | 5.52 | 4.30 | 2.94 | 1.44 | 1.02 | 2.12 |
| Levered Free Cash Flow | 554.19M | 327.53M | 597.73M | -346.13M | 75.52M | 160.53M |
| Unlevered Free Cash Flow | 554.19M | 327.53M | 600.35M | -346.13M | 75.52M | 160.53M |
| Cash Income Tax Paid | 36.29M | 98.92M | 158.51M | 100.59M | 77.82M | 45.03M |
| Change in Working Capital | -102.95M | -66.80M | -97.55M | -116.60M | -105.26M | -17.25M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 10.48B | 11.69B | 11.26B | 7.34B | 7.42B | 7.33B |
| Enterprise Value | 9.75B | 11.40B | 11.09B | 7.12B | 6.51B | 6.35B |
| Last Close Price | 78.05 | 87.31 | 82.71 | 53.29 | 74.27 | 72.20 |
| PE Ratio | 19.96 | 21.73 | 109.36 | 59.76 | 38.99 | 49.11 |
| Forward PE | 15.31 | 21.59 | 25.54 | 20.76 | 32.74 | 33.48 |
| PS Ratio | 3.33 | 3.98 | 4.47 | 4.68 | 7.25 | 7.65 |
| PB Ratio | 2.20 | 2.56 | 2.70 | 1.84 | 4.02 | 4.21 |
| P/TBV Ratio | 3.97 | 4.88 | 5.78 | 4.48 | 4.68 | 4.91 |
| P/FCF Ratio | 13.87 | 19.85 | 27.79 | 44.44 | 71.01 | 33.40 |
| P/OCF Ratio | 11.51 | 15.51 | 21.63 | 30.16 | 41.55 | 26.52 |
| PEG Ratio | 1.17 | 1.51 | 1.81 | 1.80 | 2.71 | 3.26 |
| EV/Sales Ratio | 3.10 | 3.88 | 4.40 | 4.54 | 6.36 | 6.62 |
| EV/EBITDA Ratio | 9.65 | 12.99 | 15.97 | 17.00 | 21.30 | 23.97 |
| EV/EBIT Ratio | 13.35 | 18.99 | 25.15 | 26.04 | 27.43 | 32.57 |
| EV/FCF Ratio | 12.90 | 19.36 | 27.37 | 43.11 | 62.31 | 28.93 |
| Debt / Equity Ratio | 0.02 | 0.03 | 0.13 | 0.13 | 0.00 | |
| Debt / EBITDA Ratio | 0.11 | 0.13 | 0.75 | 1.19 | 0.02 | |
| Debt / FCF Ratio | 0.15 | 0.20 | 1.33 | 3.15 | 0.06 | |
| Net Debt / Equity Ratio | -0.15 | -0.11 | -0.10 | -0.02 | -0.51 | -0.58 |
| Net Debt / EBITDA Ratio | -0.72 | -0.58 | -0.60 | -0.17 | -3.06 | -3.80 |
| Net Debt / FCF Ratio | -0.96 | -0.87 | -1.03 | -0.44 | -8.96 | -4.58 |
| Asset Turnover | 0.60 | 0.56 | 0.49 | 0.44 | 0.51 | 0.53 |
| Inventory Turnover | 1.23 | 1.32 | 1.09 | 0.83 | 0.98 | 1.03 |
| Quick Ratio | 2.78 | 2.61 | 1.72 | 2.61 | 4.17 | 4.35 |
| Current Ratio | 4.62 | 4.26 | 2.54 | 4.88 | 6.18 | 6.17 |
| Return on Equity (ROE) | 11.81% | 12.29% | 2.52% | 4.21% | 10.60% | 9.19% |
| Return on Assets (ROA) | 8.74% | 7.11% | 5.33% | 4.77% | 7.35% | 6.70% |
| Return on Invested Capital (ROIC) | 13.93% | 13.41% | 9.61% | 7.51% | 13.72% | 13.53% |
| Return on Capital Employed (ROCE) | 14.60% | 12.50% | 10.00% | 5.80% | 12.40% | 10.70% |
| Earnings Yield | 5.01% | 4.60% | 0.91% | 1.67% | 2.56% | 2.04% |
| FCF Yield | 7.21% | 5.04% | 3.60% | 2.25% | 1.41% | 2.99% |
| Buyback Yield / Dilution | 1.18% | 0.58% | -20.27% | -11.68% | 0.95% | -2.63% |